会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • CARDIAC ABLATION SYSTEM WITH PULSED AIMING LIGHT
    • 心脏吸收系统与脉冲瞄准灯
    • WO2011041629A2
    • 2011-04-07
    • PCT/US2010/051047
    • 2010-10-01
    • CARDIOFOCUS, INC.MELSKY, GeraldOSTROWSKI, Susan
    • MELSKY, GeraldOSTROWSKI, Susan
    • A61B18/18A61B18/24A61M25/10A61M29/00A61N5/06
    • A61B18/24A61B90/361A61B2017/22051A61B2017/22059A61B2018/2025A61B2090/3618
    • A method for treating a cardiac condition with visual inspection of a tissue treatment site includes the step of delivering an expanding member formed on a distal end of a catheter to a position adjacent a tissue treatment area within a patient's heart. The expandable member has an elastic portion configured to conform to the tissue treatment area. The method further includes the steps of expanding the expandable member thereby allowing the elastic portion of the expandable member to conform to the tissue treatment area and positioning an energy emitter at a first location within an inner lumen of the catheter. A visible aiming beam is projected during positioning of the energy emitter and ablative energy is delivered from the energy emitter to the tissue treatment area thereby resulting in a first spot lesion. The ablative energy is coincident with the aiming beam and the aiming beam is in the form of pulsed visible light to allow intermittent visual inspection of the first spot lesion at times when the arming beam is not projected onto the tissue treatment area, thereby allowing visual inspection of the ablative characteristics and sufficiency of the first spot lesion.
    • 用于通过目视检查组织治疗部位来治疗心脏病状的方法包括将形成在导管的远端上的扩张部件输送到患者心脏内的组织治疗区域附近的位置的步骤。 可膨胀构件具有构造成符合组织处理区域的弹性部分。 该方法还包括以下步骤:使可膨胀构件膨胀,从而允许可膨胀构件的弹性部分与组织处理区域一致,并将能量发射器定位在导管的内腔内的第一位置处。 在能量发射器的定位期间投射可见的瞄准光束,并且烧蚀能量从能量发射器传送到组织处理区域,从而导致第一斑点损伤。 烧蚀能量与瞄准光束重合,瞄准光束是脉冲可见光的形式,以允许在布防光束未投射到组织治疗区域时的第一斑点损伤的间歇性目视检查,从而允许目视检查 的烧蚀特征和充足的第一斑点病变。
    • 5. 发明申请
    • GUIDED CARDIAC ABLATION CATHETERS
    • 指导性戒毒导管
    • WO2004110258A2
    • 2004-12-23
    • PCT/US2004/018471
    • 2004-06-10
    • CARDIOFOCUS, INC.MELSKY, GeraldARNOLD, Jeffrey, M.SINOFSKY, Edward, L.FARR, Norman, E.
    • MELSKY, GeraldARNOLD, Jeffrey, M.SINOFSKY, Edward, L.FARR, Norman, E.
    • A61B
    • A61B18/24A61B2017/00057A61B2017/22051A61B2018/0022A61B2018/00982A61B2018/0212A61B2090/3937A61N7/02
    • Guided ablation instruments are disclosed for creating lesions in tissue, especially cardiac tissue for treatment of arrhythmias, including atrial fibrillation. In one aspect of the invention, a percutaneous catheter is disclosed with an endoscope positionable in the instrument's distal end region to obtain an image. The image allows the clinician to determine whether contact has been achieved (or blood has been cleared from an ablative energy transmission path) before ablation begins or while ablation is occurring. In one embodiment, percutaneous ablation catheters are disclosed having at least one central lumen and one or more balloon structures at the distal end region of the instrument. Also disposed in the distal end region are an illuminating light source and an endoscope capable of collecting sufficient light to relay an image to the user. The instruments can further include an ablation element. The ablation element can be a contact ablation element, or a radiant energy emitter, which is preferably independently positionable within the lumen of the instrument and adapted to project ablative energy through a transmissive region of the instrument body (and/or balloon) to a target tissue site proximate to the pulmonary veins. The energy can delivered without the need for contact between the energy emitter and the target tissue so long as a clear transmission pathway is established. The endoscope element of the instrument allows the clinician to determine the position of the instrument and, if radiant energy is to be employed, see if such a pathway is clear. Moreover, because the position of the radiant energy emitter can be varied, endoscopic guidance permits the clinician to select a desired location and dose for the lesion.
    • 公开了引导消融器械用于在组织中产生损伤,特别是用于治疗心律失常的心脏组织,包括房颤。 在本发明的一个方面,公开了一种经皮导管,其具有可置于仪器的远端区域中的内窥镜,以获得图像。 图像允许临床医生确定在消融开始之前还是在消融期间已经实现了接触(或者从消融能量传递路径中清除血液)。 在一个实施例中,公开了经皮消融导管,其在器械的远端区域具有至少一个中心腔和一个或多个气囊结构。 还设置在远端区域中的是能够收集足够的光以将图像中继给用户的照明光源和内窥镜。 仪器还可以包括消融元件。 消融元件可以是接触消融元件或辐射能发射器,其优选地可独立地定位在器械的内腔内并且适于将烧蚀能量穿过器械主体(和/或气囊)的透射区域投射到靶 靠近肺静脉的组织部位。 只要建立清晰的传输路径,能量可以传送而不需要能量发射器和目标组织之间的接触。 仪器的内窥镜元件允许临床医生确定仪器的位置,并且如果要使用辐射能量,看看这样的通路是否清晰。 此外,由于辐射能发射器的位置可以改变,所以内窥镜引导允许临床医生选择病变的期望位置和剂量。